Recs

0

Why Ceradyne's Shares Dropped

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Ceradyne (Nasdaq: CRDN  ) fell as much as 10% today after the company reported earnings.

So what: Revenue fell 10% from a year ago to $130.6 million, even lower than the decline to $132.1 million analysts had expected. Net income was $6.8 million, just over one-third what it was a year ago, and the $0.28 per share in earnings was $0.06 below estimates.

Now what: Ceradyne's revenue and profits are heading in the wrong direction, making even its 7.9 trailing P/E ratio fail to look like a value. Management is expecting results to be similar to what it reported in the first half of the year unless solar or defense picks up. With the economy in the rough shape it is, there are better bets than a company that has declining earnings and relies on two industries under heavy cost pressure right now. I'll pass on the sale today.

Interested in more info on Ceradyne? Add it to your Watchlist.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Fool contributor Travis Hoium has no position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings, or follow his CAPS picks at TMFFlushDraw.

The Motley Fool owns shares of Ceradyne. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days. The Motley Fool has a disclosure policy.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 24, 2012, at 7:59 PM, kurtdabear wrote:

    As a CRDN shareholder who is adding to his position this week, I would remind you not to forget the old adage about buying when blood is in the streets. (The only problem I have with that is no one has ever said how deep the blood should be when you begin operations.)

    At today's average price, CRDN is selling for about 70% of book value, carries an insignificant debt load, and pays a dividend (new this year) of nearly 3%, which is adequately covered even at the current lower rate of earnings.

    They also have a $220-million current backlog and have yet to recognize any revenue on a recently awarded a $130-million contract for Army helmets. Their solar line may never fully recover, but CRDN is a high-tech laboratory with a broad range of products serving a wide variety of industries.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1955967, ~/Articles/ArticleHandler.aspx, 5/23/2013 2:44:20 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 5 hours ago Sponsored by:
DOW 15,307.17 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
NASD 3,463.30 -38.82 -1.11%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
CRDN.DL $0.00 Down +0.00 +0.00%
Ceradyne CAPS Rating: ****

Advertisement